HCA — HCA Healthcare Income Statement
0.000.00%
Last trade - 00:00
- $80.70bn
- $122.19bn
- $64.97bn
- 92
- 56
- 96
- 95
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 51,336 | 51,533 | 58,752 | 60,233 | 64,968 |
Cost of Revenue | |||||
Gross Profit | 42,855 | 43,164 | 49,271 | 50,862 | 55,066 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 44,329 | 44,566 | 49,086 | 51,258 | 55,341 |
Operating Profit | 7,007 | 6,967 | 9,666 | 8,975 | 9,627 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 5,244 | 5,430 | 9,833 | 8,580 | 7,706 |
Provision for Income Taxes | |||||
Net Income After Taxes | 4,145 | 4,387 | 7,721 | 6,834 | 6,091 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 3,505 | 3,754 | 6,956 | 5,643 | 5,242 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 3,505 | 3,754 | 6,956 | 5,643 | 5,242 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 10.5 | 11.6 | 17.3 | 15.8 | 19 |
Dividends per Share |